Dupont Capital Management Corp Morphic Holding, Inc. Transaction History

Dupont Capital Management Corp

  • $1.19 Billion
  • Q1 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022
BUY
$19.74 - $43.01 $48,362 - $105,374
2,450 Added 65.93%
6,166 $134,000
Q1 2022

Apr 27, 2022
SELL
$36.25 - $52.02 $11,926 - $17,114
-329 Reduced 8.13%
3,716 $149,000
Q4 2021

Jan 31, 2022
SELL
$43.27 - $65.72 $69,794 - $106,006
-1,613 Reduced 28.51%
4,045 $192,000
Q3 2021

Nov 03, 2021
SELL
$53.61 - $67.5 $42,888 - $54,000
-800 Reduced 12.39%
5,658 $320,000
Q2 2021

Jul 30, 2021
BUY
$45.13 - $64.99 $291,449 - $419,705
6,458 New
6,458 $371,000

Others Institutions Holding MORF

# of Institutions
142
Shares Held
37.9M
Call Options Held
13.5K
Put Options Held
190K
View Full List

About Morphic Holding, Inc.

MORF Quotes by TradingView
  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $1.31B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Dupont Capital Management Corp Portfolio

Follow Dupont Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Dupont Capital Management Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email